Lack of Efficacy of Bevacizumab Plus Irinotecan in Children With Recurrent Malignant Glioma and Diffuse Brainstem Glioma: A Pediatric Brain Tumor Consortium Study

PURPOSE: A phase II study of bevacizumab (BVZ) plus irinotecan (CPT-11) was conducted in children with recurrent malignant glioma (MG) and intrinsic brainstem glioma (BSG). PATIENTS AND METHODS: Eligible patients received two doses of BVZ intravenously (10 mg/kg) 2 weeks apart and then BVZ plus CPT-...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Gururangan, Sridharan, Chi, Susan N., Young Poussaint, Tina, Onar-Thomas, Arzu, Gilbertson, Richard J., Vajapeyam, Sridhar, Friedman, Henry S., Packer, Roger J., Rood, Brian N., Boyett, James M., Kun, Larry E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2010
Konular:
Original Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903337/
https://ncbi.nlm.nih.gov/pubmed/20479404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.26.8789
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller